Sign inJoin waitlistJoin the waitlist

Elizabeth Alva

Director, Pediatric Cancer Predisposition Screening Program · University of Alabama Hospital

Credentials: · · · ·

History

University of Alabama Hospital
Present

Pediatric Hematology-Oncology
Children's of Alabama
2011–2012
Children's Hospital Colorado
2008–2011
University of Alabama at Birmingham
Med Coll of Georgia
2004–2008

Research

Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2024 · 96 citations
Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features
Brain Pathology · 2020 · 58 citations
Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor
Neoplasia · 2023 · First of 7 authors · 33 citations

RL
Rong Li
4 papers
Alyssa Reddy
3 papers
Andrew Bollen
2 papers · 2 as a fellow
Arie Perry
2 papers
David Solomon
2 papers
Douglas Fair
2 papers
GL
Geling Li
2 papers
James Grenert
2 papers
James Johnston
2 papers
Julieann Lee
2 papers · 2 as a fellow
Melike Pekmezci
2 papers
Mitchel Berger
2 papers

Clinical trials

Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
2020–2027
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Site PI · Recruiting · Phase 1, Phase 2
Milton S. Hershey Medical Center
2026–2035
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
Site PI · Recruiting · Phase 1
H. Lee Moffitt Cancer Center and Research Institute
2026–2030
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2029